OBJECTIVES: The aim of this study is to construct a nomogram for predicting subsequent early pregnancy loss in women with a history of pregnancy loss, which may increase well-being and the capacity for managing reproductive options. MATERIALS AND METHODS: We conducted a retrospective analysis of medical records from women with a history of pregnancy loss at the Reproductive Medicine Center of Lanzhou University Second Hospital between January 2019 and December 2022. A cohort of 718 patients was selected for the study. We structured our data into a training set of 575 cases (80% of the cohort) and a test set of 143 cases (20%). To identify significant predictors, we applied a stepwise forward algorithm guided by the Akaike Information Criterion (AIC) to the training set. Model validation was conducted using the test set. For the validation process, we employed various methods to assess the predictive power and accuracy of the model. Receiver Operating Characteristic (ROC) curves provided insights into the model's ability to distinguish between outcomes effectively. Calibration curves assessed the accuracy of the probability predictions against actual outcomes. The clinical utility of the model was further evaluated through Decision Curve Analysis, which quantified the net benefits at various threshold probabilities. In addition, a nomogram was developed to visually represent the risk factors. RESULTS: Among the 36 candidate variables initially considered, 10 key predictors were identified through logistic regression analysis and incorporated into the nomogram. These selected variables include age, education, thrombin time (TT), antithrombin III (AT-III), D-dimer levels, 25-hydroxy Vitamin D, immunoglobulin G(IgG), complement components C4, anti-cardiolipin antibody (ACA) and lupus anticoagulant (LA). In addition, based on clinical experience, the number of previous pregnancy losses was also included as a predictive variable. The prediction model revealed an area under the curve (AUC) of approximately 0.717 for the training set and 0.725 for the validation set. Calibration analysis indicated satisfactory goodness-of-fit, with a Hosmer-Lemeshow test yielding a χ2 value of 7.78 (p = 0.55). Decision curve analysis confirmed the clinical utility of the nomogram. Internal validation confirmed the robust performance of the predictive model. CONCLUSIONS: The constructed nomogram provides a valuable tool for predicting subsequent early pregnancy loss in women with a history of pregnancy loss. This nomogram can assist clinicians and patients in making informed decisions regarding the management of pregnancy and improving clinical outcomes. TRIAL REGISTRATION: This study was registered in the Chinese Clinical Trial Registry under the registration number ChiCTR2000039414 on October 27, 2020. The registration was done retrospectively.